Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies

被引:2
作者
Paranjpe, Madhav G. [1 ]
Belich, Jessica L. [1 ]
Richardson, Dayauna R. [1 ]
Vidmar, Tom [2 ]
Mann, Peter C. [3 ]
McKeon, Marie E. [1 ]
Elbekai, Reem H. [4 ]
Brown, Caren [1 ]
机构
[1] BioReliance SAFC, 14920 Broschart Rd, Rockville, MD 20850 USA
[2] BioSTAT Consultants Inc, Portage, MI USA
[3] Expt Pathol Labs, Seattle, WA USA
[4] PAREXEL Int, Bethesda, MD USA
关键词
Tg.rasH2; nasal cavity; exudative inflammation; historical incidence; nasal cavity tumors; carcinogenicity studies; RATS; REFLUX;
D O I
10.1177/1091581816673583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three levels of nasal cavity sections (anterior, middle, and most posterior) are routinely examined as protocol required tissues in our 26-week carcinogenicity studies involving Tg.rasH2 mice. Exudative inflammation of the nasal cavity was noted in the most posterior section of both males and females that were administered vehicle and/or test article via oral gavage, particularly when the vehicle and/or test article had irritant properties, was in the form of a salt, had a low pH, and/or was viscous. The exudative inflammatory lesion was characterized by the presence of eosinophilic proteinaceous fluid, fibrin, mucin, sloughed cells, and degenerate neutrophils within the nasal cavities. In lesions of increased severity, there was often degeneration, necrosis, and erosion of the underlying mucosa. Often, there was hyperplasia as well as squamous metaplasia of the mucosa. Retrospective analysis of our data, involving thirty-two 26-week Tg.rasH2 carcinogenicity studies, revealed that despite the presence of these exudative inflammatory changes with degeneration, necrosis, and mucosal hyperplasia, progression to tumor formation in the nasal cavities was rare and the incidence of nasal tumors was comparable in animals with or without exudative inflammatory lesions.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 14 条
[1]  
[Anonymous], 2001, GUID IND STAT ASP DE
[2]   TESTS FOR LINEAR TRENDS IN PROPORTIONS AND FREQUENCIES [J].
ARMITAGE, P .
BIOMETRICS, 1955, 11 (03) :375-386
[3]   SOME METHODS FOR STRENGTHENING THE COMMON X2 TESTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (04) :417-451
[4]   IMPROVED ORAL DOSING TECHNIQUE FOR RATS [J].
CONYBEARE, G ;
LESLIE, GB .
JOURNAL OF PHARMACOLOGICAL METHODS, 1988, 19 (02) :109-116
[5]   Unexpected Nasal Changes in Rats Related to Reflux after Gavage Dosing [J].
Damsch, Siegrid ;
Eichenbaum, Gary ;
Looszova, Adriana ;
Lammens, Lieve ;
Feyen, Bianca ;
Van den Bulck, Kathleen ;
Knight, Elaine ;
Kelley, Michael ;
Tonelli, Alfred .
TOXICOLOGIC PATHOLOGY, 2011, 39 (02) :337-347
[6]   Gavage-Related Reflux in Rats: Identification, Pathogenesis, and Toxicological Implications (Review) [J].
Damsch, Siegrid ;
Eichenbaum, Gary ;
Tonelli, Alfred ;
Lammens, Lieve ;
Van den Bulck, Kathleen ;
Feyen, Bianca ;
Vandenberghe, John ;
Megens, Anton ;
Knight, Elaine ;
Kelley, Michael .
TOXICOLOGIC PATHOLOGY, 2011, 39 (02) :348-360
[7]   Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies [J].
Eichenbaum, G. ;
Damsch, S. ;
Looszova, A. ;
Vandenberghe, J. ;
Van den Bulck, K. ;
Roels, K. ;
Megens, A. ;
Knight, E. ;
Hillsamer, V. ;
Feyen, B. ;
Kelley, M. F. ;
Tonelli, A. ;
Lammens, L. .
JOURNAL OF APPLIED TOXICOLOGY, 2011, 31 (04) :342-354
[8]  
Haschek W.M., 2002, HDB TOXICOLOGIC PATH, P3
[9]  
International Conference on Harmonisation, 1998, FED REGISTER, V63, P8983
[10]   Regulatory Forum Opinion Piece*: Transgenic/Alternative Carcinogenicity Assays: A Retrospective Review of Studies Submitted to CDER/FDA 1997-2014 [J].
Jacobs, Abigail C. ;
Brown, Paul C. .
TOXICOLOGIC PATHOLOGY, 2015, 43 (05) :605-610